SEC Form 4 · accession 0001654954-18-014238
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mehmood Khan
Director
Period of report
Dec 20, 2018
Accepted (ET)
Dec 21, 2018 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 20, 2018 | P | 100,000 | $1.2441 | A | 564,583 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F1 | $0.57 | holding | — | — | — | — | Feb 16, 2028 | Common Stock | 40,000 | 40,000 | D |
| Stock Option (Right to Buy Common Stock)F2 | $0.45 | holding | — | — | — | — | Jun 25, 2027 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1These options were granted on 2/16/2018. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F2These options were granted on 6/25/2017. These options vest 1/3 on the date of grant, 1/3 on the first anniversary of the date of grant and 1/3 on the second anniversary of the date of grant.